Balance Sheet - Zenas BioPharma, Inc. (ZBIO)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | |
|---|---|---|---|---|
| Total cash and short-term investments | 0.34 | 0.35 | 0.06 | 0.07 |
| Other current assets | 0.01 | 0.01 | 0.00 | 0.00 |
| Total current assets | 0.35 | 0.36 | 0.06 | 0.07 |
| Total non-current assets | 0.03 | 0.01 | 0.01 | 0.01 |
| Total assets | 0.38 | 0.37 | 0.07 | 0.07 |
| Total current liabilities | 0.06 | 0.06 | 0.02 | 0.03 |
| Total non-current liabilities | 0.08 | 0.00 | 0.27 | 0.24 |
| Total liabilities | 0.14 | 0.06 | 0.29 | 0.27 |
| Total stockholders' equity | 0.24 | 0.31 | -0.23 | -0.19 |
| Common shares outstanding | 45 | 42 | 38 | 38 |
Show Quarterly Balance Sheet
Balance Sheet - Zenas BioPharma, Inc. (ZBIO)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.72 | 0.34 | 0.29 | 0.27 | 0.31 | 0.35 | 0.39 | 0.18 | 0.04 | 0.06 | 0.07 | 0.00 | 0.07 | 0.07 |
| Accounts receivable, net | 0.00 | |||||||||||||
| Other current assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Total current assets | 0.73 | 0.35 | 0.30 | 0.28 | 0.32 | 0.36 | 0.39 | 0.19 | 0.04 | 0.06 | 0.08 | 0.07 | 0.07 | |
| Total non-current assets | 0.02 | 0.03 | 0.03 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | -0.07 | 0.01 | |
| Total assets | 0.75 | 0.38 | 0.32 | 0.29 | 0.33 | 0.37 | 0.40 | 0.20 | 0.05 | 0.07 | 0.08 | 0.07 | ||
| Total current liabilities | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.06 | 0.04 | 0.04 | 0.03 | 0.02 | 0.02 | 0.03 | ||
| Total non-current liabilities | 0.35 | 0.08 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.27 | 0.27 | -0.05 | 0.24 | |
| Total liabilities | 0.41 | 0.14 | 0.13 | 0.05 | 0.05 | 0.06 | 0.04 | 0.04 | 0.30 | 0.29 | 0.29 | -0.05 | 0.27 | |
| Total stockholders' equity | 0.34 | 0.24 | 0.20 | 0.24 | 0.28 | 0.31 | 0.36 | 0.16 | -0.25 | -0.23 | -0.20 | 0.05 | -0.19 | |
| Common shares outstanding | 56 | 46 | 42 | 42 | 42 | 42 | 42 | 38 | 38 | 38 | 42 | 38 | 38 | 38 |